The U.S. Supreme Court on Monday for the second time did not announce whether it would hear an appeal by Teva Pharmaceuticals in a patent fight with generic competitors over its top-selling multiple sclerosis drug Copaxone. The nine justices are considering whether to review a July 2013 ruling by the U.S. Court of Appeals in favor of two cheaper generic forms of Copaxone by Novartis … Continue reading Healthcare Bullish Stocks: Momenta Pharmaceuticals (NASDAQ:MNTA), Orthofix International (NASDAQ:OFIX), Oxygen Biotherapeutics (NASDAQ:OXBT), Curis (NASDAQ:CRIS)